{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:43:29Z","timestamp":1781754209021,"version":"3.54.5"},"reference-count":5,"publisher":"Norwegian Medical Association","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2013,8,20]]},"DOI":"10.4045\/tidsskr.13.0866","type":"journal-article","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T08:31:22Z","timestamp":1377246682000},"page":"1553-4","source":"Crossref","is-referenced-by-count":2,"title":["Aminoglykosider ved alvorlig sepsis"],"prefix":"10.4045","volume":"133","author":[{"given":"Jon Birger","family":"Haug","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Berild","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn","family":"Blomberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan N.","family":"Bruun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans K.","family":"Flaatten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Alexander","family":"Leiva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steinar","family":"Skrede","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Torfoss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ystein","family":"Undseth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Nord\u00f8y I, Laake JH. Uforsvarlige retningslinjer for antibiotikabruk i\u00a0sykehus. Tidsskr Nor Legeforen 2013; 133: 1056. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23712164&dopt=Abstract","DOI":"10.4045\/tidsskr.13.0376"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Kumar A, Zarychanski R, Light B et al. Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Crit Care Med 2010; 38: 1773\u2009\u2013\u200985. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20639750&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097\/CCM.0b013e3181eb3ccd","DOI":"10.1097\/CCM.0b013e3181eb3ccd"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Hanberger H, Edlund C, Furebring M et al. Rational use of aminoglycosides\u2013review and recommendations by the Swedish Reference Group for Antibiotics (SRGA). Scand J Infect Dis 2013; 45: 161\u2009\u2013\u200975. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23270477&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.3109\/00365548.2012.747694","DOI":"10.3109\/00365548.2012.747694"},{"key":"ref=4","unstructured":"Brink M, Cronqvist J, Furebring M et al. V\u00e5rdprogram. Sv\u00e5r sepsis och septisk chock \u2013 tidlig identifiering och initial handl\u00e4gging 2012. http:\/\/infektion.net\/kunder\/infektion\/kunder\/infektion\/sites\/default\/files\/6\/Vardprogram_svarsepsis__2012.pdf (26.6.2013)."},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Paul M, Benuri-Silbiger I, Soares-Weiser K et al. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ 2004; 328: 668. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14996699&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136\/bmj.38028.520995.63","DOI":"10.1136\/bmj.38028.520995.63"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:57:14Z","timestamp":1781650634000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2013\/08\/brev-til-redaktoren\/aminoglykosider-ved-alvorlig-sepsis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,20]]},"references-count":5,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2013,8,20]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.13.0866","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,20]]}}}